| 1 |
-
Metabolomics in chronic hepatitis C: Decoding fibrosis grading and underlying pathways
-
11/24/2023 6:10:12 AM | Browse: 185 | Download: 674
|
| 2 |
-
Acute-on-chronic liver failure induced by antiviral therapy for chronic hepatitis C: A case report
-
10/25/2023 8:49:11 AM | Browse: 234 | Download: 588
|
| 3 |
-
Longitudinal assessment of liver stiffness by transient elastography for chronic hepatitis C patients
-
6/9/2022 7:17:55 AM | Browse: 450 | Download: 1674
|
| 4 |
-
Direct-acting antivirals for chronic hepatitis C treatment: The experience of two tertiary university centers in Brazil
-
1/21/2022 8:16:14 AM | Browse: 530 | Download: 1078
|
| 5 |
-
Survival and outcomes for co-infection of chronic hepatitis C with and without cirrhosis and COVID-19: A multicenter retrospective study
-
11/10/2021 7:13:09 AM | Browse: 712 | Download: 1053
|
| 6 |
-
Platelet count as a screening tool for compensated cirrhosis in chronic viral hepatitis
-
5/14/2021 10:27:31 AM | Browse: 628 | Download: 1259
|
| 7 |
-
Factors influencing the failure of interferon-free therapy for chronic hepatitis C: Data from the Polish EpiTer-2 cohort study
-
5/10/2021 7:46:10 AM | Browse: 448 | Download: 1194
|
| 8 |
-
Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyond
-
4/29/2021 2:12:02 AM | Browse: 504 | Download: 1044
|
| 9 |
-
Production and activity of metalloproteinases during liver fibrosis progression of chronic hepatitis C patients
-
2/25/2021 3:45:30 PM | Browse: 750 | Download: 1641
|
| 10 |
-
Management of hepatitis C in children and adolescents during COVID-19 pandemic
-
8/25/2020 9:16:00 AM | Browse: 754 | Download: 1399
|
| 11 |
-
Liver-related effects of chronic hepatitis C antiviral treatment
-
6/14/2020 1:45:26 PM | Browse: 941 | Download: 1645
|
| 12 |
-
Interleukin-6-174G/C polymorphism is associated with a decreased risk of type 2 diabetes in patients with chronic hepatitis C virus
-
4/23/2020 10:34:55 AM | Browse: 644 | Download: 1785
|
| 13 |
-
Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C
-
1/13/2020 11:27:12 AM | Browse: 1164 | Download: 1561
|
| 14 |
-
Effects of dual sofosbuvir/daclatasvir therapy on, chronic hepatitis C infected, survivors of childhood malignancy
-
8/26/2019 2:56:47 AM | Browse: 818 | Download: 2215
|
| 15 |
-
High prevalence of occult hepatitis C infection in predialysis patients
-
1/27/2019 7:04:05 AM | Browse: 891 | Download: 1642
|
| 16 |
-
Challenge to overcome: Nonstructural protein 5A-P32 deletion in direct-acting antiviral-based therapy for hepatitis C virus
-
10/12/2018 5:32:21 AM | Browse: 782 | Download: 1171
|
| 17 |
-
Daclatasvir plus asunaprevir in treatment-naïve patients with hepatitis C virus genotype 1b infection
-
3/26/2018 8:48:04 AM | Browse: 1303 | Download: 2577
|
| 18 |
-
Proton nuclear magnetic resonance-based metabonomic models for non-invasive diagnosis of liver fibrosis in chronic hepatitis C: Optimizing the classification of intermediate fibrosis
-
1/26/2018 8:09:36 AM | Browse: 1115 | Download: 1726
|
| 19 |
-
Efficacy and safety of sofosbuvir and ledipasvir in japanese patients aged 75 years or over with hepatitis C genotype 1
-
12/27/2017 10:31:19 AM | Browse: 1145 | Download: 2085
|
| 20 |
-
Hepatitis C virus NS5A region mutation in chronic hepatitis C genotype 1 patients who are non-responders to two or more treatments and its relationship with response to a new treatment
-
7/7/2017 11:41:16 AM | Browse: 1075 | Download: 2115
|
| 21 |
-
Interferon related pericarditis: Review
-
6/26/2017 12:49:43 AM | Browse: 1122 | Download: 1464
|
| 22 |
-
Efficacy and safety of combined directly acting antivirals for treatment of Chinese chronic hepatitis C patients in a real-world setting
-
6/14/2017 9:25:57 AM | Browse: 1101 | Download: 2139
|
| 23 |
-
Prevalence of IFNL3 rs4803217 single nucleotide polymorphism and clinical course of chronic hepatitis C
-
6/7/2017 7:22:42 AM | Browse: 1851 | Download: 3451
|
| 24 |
-
Inducible protein-10 as a predictive marker of antiviral hepatitis C treatment: A systematic review
-
5/17/2017 6:29:40 AM | Browse: 1412 | Download: 2150
|
| 25 |
-
Impact of interferon-free antivirus therapy on lipid profiles in patients with chronic hepatitis C genotype 1b
-
4/6/2017 6:30:00 PM | Browse: 1234 | Download: 1798
|
| 26 |
-
Fibrosis assessment using FibroMeter combined to first generation tests in hepatitis C
-
2/27/2017 8:50:00 AM | Browse: 1225 | Download: 1709
|
| 27 |
-
Influence of vitamin D on liver fibrosis in chronic hepatitis C: A systematic review and meta-analysis of the pooled clinical trials data
-
2/17/2017 8:32:00 AM | Browse: 1197 | Download: 1719
|
| 28 |
-
Angiopoietin-2/angiopoietin-1 as non-invasive biomarker of cirrhosis in chronic hepatitis C
-
11/26/2016 6:56:00 PM | Browse: 1195 | Download: 2465
|
| 29 |
-
Collision tumor of hepatocellular carcinoma and neuroendocrine carcinoma involving the liver: Case report and review of the literature
-
11/6/2016 3:43:00 PM | Browse: 981 | Download: 1435
|
| 30 |
-
Hepatitis C and double-hit B cell lymphoma successfully treated by antiviral therapy
-
10/14/2016 1:37:00 PM | Browse: 1255 | Download: 1483
|
| 31 |
-
Impact of hepatitis C virus core mutations on the response to interferon-based treatment in chronic hepatitis C
-
9/30/2016 5:59:00 PM | Browse: 1220 | Download: 2296
|
| 32 |
-
Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication
-
9/4/2016 2:49:00 PM | Browse: 1409 | Download: 2007
|
| 33 |
-
Hepatitis C virus G1b infection decreases the number of small low-density lipoprotein particles
-
7/29/2016 8:32:00 PM | Browse: 1162 | Download: 1776
|
| 34 |
-
Transient elastography compared to liver biopsy and morphometry for predicting fibrosis in pediatric chronic liver disease: Does etiology matter?
-
4/19/2016 9:45:00 AM | Browse: 1240 | Download: 2770
|
| 35 |
-
Daclatasvir vs telaprevir plus peginterferon alfa/ribavirin for hepatitis C virus genotype 1
-
3/23/2016 4:26:00 PM | Browse: 1399 | Download: 2276
|
| 36 |
-
Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damage
-
1/20/2016 5:04:00 PM | Browse: 1314 | Download: 1569
|
| 37 |
-
Hepcidin/ferroportin expression levels involve efficacy of pegylated-interferon plus ribavirin in hepatitis C virus -infected liver
-
12/10/2015 10:35:00 AM | Browse: 1170 | Download: 1511
|
| 38 |
-
Comparison of peg-interferon, ribavirin plus telaprevir vs simeprevir by propensity score matching
-
12/4/2015 3:24:00 PM | Browse: 1188 | Download: 2363
|
| 39 |
-
Treatment of chronic hepatitis C in patients with HIV/HCV coinfection
-
12/2/2015 12:06:00 PM | Browse: 588 | Download: 1048
|
| 40 |
-
Importance of virological response in the early stage of telaprevir-based triple therapy for hepatitis C
-
11/18/2015 11:12:00 AM | Browse: 1091 | Download: 1345
|
| 41 |
-
Factors associated with the response to interferon-based antiviral therapies for chronic hepatitis C
-
11/18/2015 11:12:00 AM | Browse: 1138 | Download: 1881
|
| 42 |
-
Era of direct acting antivirals in chronic hepatitis C: Who will benefit?
-
10/30/2015 11:57:00 AM | Browse: 1537 | Download: 1824
|
| 43 |
-
Hepatitis C virus markers in infection by hepatitis C virus: In the era of directly acting antivirals
-
10/14/2015 12:06:00 PM | Browse: 1233 | Download: 1709
|
| 44 |
-
Hepatitis C virus infection and prisoners: Epidemiology, outcome and treatment
-
9/23/2015 12:28:00 PM | Browse: 1819 | Download: 2077
|
| 45 |
-
Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patients
-
8/8/2015 3:25:00 PM | Browse: 1156 | Download: 2352
|
| 46 |
-
Boceprevir early-access for advanced-fibrosis/cirrhosis in Asia-pacific hepatitis C virus genotype 1 non-responders/relapsers
-
7/30/2015 11:19:00 AM | Browse: 1316 | Download: 1771
|
| 47 |
-
Severe immune thrombocytopenia after peg-interferon-alpha2a, ribavirin and telaprevir treatment completion: a case report and systematic review of literature
-
6/29/2015 5:40:00 PM | Browse: 1042 | Download: 1686
|
| 48 |
-
Impact of direct acting antiviral-based triple therapy on the serum alpha-fetoprotein level
-
4/30/2015 2:11:00 PM | Browse: 1091 | Download: 1872
|
| 49 |
-
Management of hepatitis C infection before and after liver transplantation
-
4/30/2015 2:11:00 PM | Browse: 1130 | Download: 1640
|
| 50 |
-
Insulin-like growth factor-1 mRNA isoforms and insulin-like growth factor-1 receptor mRNA expression in chronic hepatitis C
-
4/7/2015 6:08:00 PM | Browse: 1079 | Download: 1816
|
